“PRO PLUS” TOPICAL ANESTHETIC “PRO PLUS” TOPICAL ANESTHETIC For Use by Licensed Professionals Only. For Use by Licensed Professionals Only.
This pre-deadener was developed by a pharmacist familiar with our industries.
This pre-deadener was developed by a pharmacist familiar with our industries.
Previous versions of this anesthetic have been used successfully for years. This
Previous versions of this anesthetic have been used successfully for years. This
recent alteration has improved its speed and depth of anesthesia. This cream
recent alteration has improved its speed and depth of anesthesia. This cream
contains 2% tetracaine and 4% lidocaine, has a pH of 7 and is safe for eyeliner.
contains 2% tetracaine and 4% lidocaine, has a pH of 7 and is safe for eyeliner.
FOR EXTERNAL USE ONLY ON INTACT SKIN: Check with client for history FOR EXTERNAL USE ONLY ON INTACT SKIN: Check with client for history
of allergic reactions to topical anesthetics before applying. Keep in a cool dark
of allergic reactions to topical anesthetics before applying. Keep in a cool dark
place, out of the reach of children.
place, out of the reach of children. WARNING: Avoid direct contact with the eyeball. If contact should occur, WARNING: Avoid direct contact with the eyeball. If contact should occur,
irrigate with copious amounts of sterile saline and contact an eye care physician.
irrigate with copious amounts of sterile saline and contact an eye care physician.
DO NOT SWALLOW. If accidentally swallowed, seek medical help immediately.
DO NOT SWALLOW. If accidentally swallowed, seek medical help immediately.
EYEBROWS 15- 20 minutes EYEBROWS 15- 20 minutes
For best results, lightly exfoliate with Skin Resurfacer prior to application.
For best results, lightly exfoliate with Skin Resurfacer prior to application.
Gently massage into skin and then apply a medium coating over the top. Cover
Gently massage into skin and then apply a medium coating over the top. Cover
with a plastic (occlusive) dressing. Wipe away immediately prior to tattooing.
with a plastic (occlusive) dressing. Wipe away immediately prior to tattooing.
EYELINER 15- 20 minutes EYELINER 15- 20 minutes
Fill the eyes with liquid eye gel to coat the cornea. With the client’s eyes closed,
Fill the eyes with liquid eye gel to coat the cornea. With the client’s eyes closed,
apply a thin layer of cream with a small applicator across the lash line. Remove
apply a thin layer of cream with a small applicator across the lash line. Remove
anesthetic before beginning procedure. Following the first pass of tattooing,
anesthetic before beginning procedure. Following the first pass of tattooing,
sparingly apply Zone 2 or Blue Gel to control swelling and maintain anesthesia
sparingly apply Zone 2 or Blue Gel to control swelling and maintain anesthesia
15-20 minutes 15-20 minutes
For best results, lightly exfoliate with Skin Resurfacer prior to application.
For best results, lightly exfoliate with Skin Resurfacer prior to application.
Gently massage into skin and then apply a medium coating over the top. Cover
Gently massage into skin and then apply a medium coating over the top. Cover
with a plastic (occlusive) dressing. Wipe away immediately prior to tattooing.
with a plastic (occlusive) dressing. Wipe away immediately prior to tattooing.
While some relief may be provided with topical anesthetics, for total
While some relief may be provided with topical anesthetics, for total
anesthesia, you must provide a nerve block performed by a physician. Do not
anesthesia, you must provide a nerve block performed by a physician. Do not use inside of the mouth. Use SJ3 during procedure to continue anesthesia, or either use inside of the mouth. Use SJ3 during procedure to continue anesthesia, or either APPLICATION TIMES APPLICATION TIMES D Blue Gel, Vasocaine or Zone 2 to continue anesthesia and constrict blood vessels. D Blue Gel, Vasocaine or Zone 2 to continue anesthesia and constrict blood vessels. BODY SKIN 90-120 minutes BODY SKIN 90-120 minutes
Prior to tattooing or piercing: Lightly exfoliate with Skin Resurfacer. Gently
Prior to tattooing or piercing: Lightly exfoliate with Skin Resurfacer. Gently
massage into skin and then apply a medium coating over the top. In order to
massage into skin and then apply a medium coating over the top. In order to
prevent absorption into clothing and retain effective anesthesia, cover with an
prevent absorption into clothing and retain effective anesthesia, cover with an
SUGGESTE occlusive dressing. Thicker skin requires longer time to absorb the cream than SUGGESTE occlusive dressing. Thicker skin requires longer time to absorb the cream than
thinner skin. Use SJ3 during procedure to continue anesthesia, or either Blue
thinner skin. Use SJ3 during procedure to continue anesthesia, or either Blue Gel, Vasocaine or Zone 2 to continue anesthesia and constrict blood vessels. Gel, Vasocaine or Zone 2 to continue anesthesia and constrict blood vessels. PIERCING 15- 20 minutes PIERCING 15- 20 minutes
Apply to eyebrows, navels and nipples. Avoid genital areas. Thicker skin
Apply to eyebrows, navels and nipples. Avoid genital areas. Thicker skin
requires longer pre-treating time. Lightly exfoliate with Skin Resurfacer. Gently
requires longer pre-treating time. Lightly exfoliate with Skin Resurfacer. Gently
massage into skin, then apply a medium coating on top. Cover with occlusive
massage into skin, then apply a medium coating on top. Cover with occlusive
dressing. Wipe away immediately prior to piercing. Use Blue Gel or Zone 2
dressing. Wipe away immediately prior to piercing. Use Blue Gel or Zone 2
during jewelry insertion to continue anesthesia and reduce swelling.
during jewelry insertion to continue anesthesia and reduce swelling.
DERMAL SOURCE DERMAL SOURCE 1017 SW Morrison Street, #210 1017 SW Morrison Street, #210 Portland, Oregon 97205 Portland, Oregon 97205 Phone: 866-568-3223, Fax: 503-973-5433 Phone: 866-568-3223, Fax: 503-973-5433 www.dermalsouce.com www.dermalsouce.com
Biochemical Society Transactions (2003) Volume 31, part 2 Transgenic mouse models for studies of the role of polyamines in normal, hypertrophic and neoplastic growth A.E. Pegg*1, D.J. Feith*, L.Y.Y. Fong†, C.S. Coleman*, T.G. O’Brien‡ and L.M. Shantz* *Department of Cellular and Molecular Physiology, The Milton S. Hershey Medical Center, Pennsylvania State University College of Medicine
Résumé des Caractéristiques du Produithttp://afssaps-prd.afssaps.fr/php/ecodex/rcp/R0124988.htm 1. DENOMINATION DU MEDICAMENT SELOZOK L.P. 23,75 mg, comprimé pelliculé sécable à libération prolongée 2. COMPOSITION QUALITATIVE ET QUANTITATIVE Pour la liste complète des excipients, voir rubrique 6.1. 3. FORME PHARMACEUTIQUE Comprimé pel iculé sécable à libération prolong